That it is the sense of the House of Representatives that policies governing blood and blood product donation in the United States should— (1) be grounded in science; (2) minimize deferral periods; (3) be based on individual risk factors; (4) not unfairly single out any group of individuals; and (5) allow donations by all those who can safely do so.